Alexandria Real Estate Equities (ARE)
NYSEReal EstateReit - OfficeSnapshot 2026-07-07
$49.41-0.92%
Close 2026-07-07 · 1-day change
Reading ARE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track ARE free→NYSEReal EstateReit - OfficeSnapshot 2026-07-07
Reading ARE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track ARE free→QuarterlyIQ Insights · ARE
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 4 valuation methods, at three horizons. Current price $49.41. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $49 ARE trades at 35× p/ffo — 2.2× the 16× p/ffo peer median. The market is re-rating it beyond its own range; our $78 fair value is low-confidence here. Analysts target $43–$60. Note: our $78 fair value sits above the entire analyst range ($43–$60). Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price sits about 37% below a flat-multiple fair value, while analysts forecast about -8% growth — below our forecast. This describes what's priced in, not a forecast of the move.
TTM earnings are negative, so the read leans on sales- and cash-flow-based methods rather than P/E. This is a data condition, not a forward call.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $53.00 | — | — | Analyst | high |
| Mgmt guidance | 12M | $103.55 | 16.2 | 6.40 | Mgmt | high |
| Peer P/FFO | 12M | $22.56 | 16.2 | 1.39 | TTM | high |
| Peer P/S | 12M | $136.54 | 7.9 | 17.20 | TTM | high |
| Peer P/S | 3Y |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
$43.00 – $60.00 (median $53.00) · 9 analysts · as of 2026-07-06
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $150.05 |
| 7.9 |
| 18.91 |
| Hist. CAGR(prov.) |
| medium |
| Peer P/S | 5Y | $159.80 | 7.9 | 20.13 | Hist. CAGR(prov.) | medium |